{
    "eid": "2-s2.0-85128245776",
    "title": "Durable clearance rate of photodynamic therapy for Bowen disease and cutaneous squamous cell carcinoma: A systematic review and meta-analysis",
    "cover-date": "2022-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Surgery",
            "@code": "2746",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Dermatology",
            "@code": "2708",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Tanat Yongpisarn",
        "Rachel Rigo",
        "Kira Minkis"
    ],
    "citedby-count": 0,
    "ref-count": 50,
    "ref-list": [
        "Photodynamic therapy: Influence of clinical and procedure variables on treatment response in basal cell carcinoma and bowen disease",
        "Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: Optimizing patient selection",
        "Photodynamic therapy for Bowen\u2019s disease and squamous cell carcinoma of the skin",
        "Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid",
        "Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial",
        "Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen\u2019s disease",
        "Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen\u2019s disease): A randomized, double-blind, placebo-controlled trial",
        "Interventions for non-metastatic squamous cell carcinoma of the skin: Systematic review and pooled analysis of observational studies",
        "Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions",
        "British Association of Dermatologists\u2019 guidelines for the management of squamous cell carcinoma in situ (Bowen\u2019s disease) 2014",
        "Methylaminolaevulinate-based photodynamic therapy of Bowen\u2019s disease and squamous cell carcinoma",
        "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement",
        "RoB 2: A revised tool for assessing risk of bias in randomised trials",
        "RobiNS-I: A tool for assessing risk of bias in non-randomised studies of interventions",
        "Methyl aminolevulinate-based photodynamic therapy of Bowen\u2019s disease: Observational study of 21 lesions",
        "Treatment of Bowen\u2019s disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL)",
        "Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen\u2019s disease in clinical practice: A retrospective cohort study (2006-2017)",
        "Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease",
        "Presence of human papillomavirus 16 in acral Bowen disease as a predictor of a less efficacious response to photodynamic therapy: A retrospective case series of nine patients",
        "Treatment of bowen disease with photodynamic therapy and the advantages of sequential topical Imiquimod",
        "Photodynamic therapy in Bowen\u2019s disease: Influence of histological features and clinical characteristics on its success",
        "A study of topical methyl-aminolaevulinate red-light photodynamic therapy in the treatment of actinic keratosis in Chinese patients: A Singaporean experience",
        "Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department",
        "Fluorescence diagnosis and photodynamic therapy for Bowen\u2019s disease treatment",
        "A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: Results from a 12-month follow-up",
        "Effectiveness of photodynamic therapy in Bowen\u2019s disease: An observational and descriptive study in 51 lesions",
        "Photodynamic therapy in the treatment of extensive Bowen\u2019s disease",
        "5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer",
        "Long-term followup of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen\u2019s disease",
        "Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and nonmelanoma skin cancers: A retrospective analysis of response in 462 patients",
        "An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer",
        "Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer",
        "Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years",
        "Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma",
        "Comparison of red and green light in the treatment of Bowen\u2019s disease by photodynamic therapy",
        "Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen\u2019s disease",
        "Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer",
        "A clinical trial using attrition combined with 5-aminolevulinic acids based photodynamic therapy in treating squamous cell carcinoma",
        "Effect of methyl aminolevulinate photodynamic therapy with and without ablative fractional laser treatment in patients with microinvasive squamous cell carcinoma: A randomized clinical trial",
        "Using photodynamic therapy as a neoadjuvant treatment in the surgical excision of nonmelanotic skin cancers: Prospective study",
        "Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture",
        "Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen\u2019s disease",
        "Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: A case series and review of the literature",
        "Clinical responses to topical photodynamic therapy of actinic keratoses, bowen\u2019s disease and non-oncological diseases in Japan",
        "Comparison of photodynamic therapy for skin cancers and pre-cancers with d-aminolevulinic acid",
        "Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer",
        "Investigation of the use of the pulsed dye laser in the treatment of Bowen\u2019s disease using 5-aminolaevulinic acid phototherapy",
        "Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours",
        "Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer",
        "Response of bowen disease to ALA-PDT using a single and a 2-fold illumination scheme"
    ],
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60007997",
            "affilname": "Weill Cornell Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}